- Home
- GOSS vs BCML Comparison
GOSS vs BCML Comparison
Compare GOSS & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- BCML
- Stock Information
- Founded
- GOSS 2015
- BCML 2004
- Country
- GOSS United States
- BCML United States
- Employees
- GOSS N/A
- BCML N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- BCML Major Banks
- Sector
- GOSS Health Care
- BCML Finance
- Exchange
- GOSS Nasdaq
- BCML Nasdaq
- Market Cap
- GOSS 214.7M
- BCML 261.8M
- IPO Year
- GOSS 2019
- BCML N/A
- Fundamental
- Price
- GOSS $0.97
- BCML $24.19
- Analyst Decision
- GOSS Strong Buy
- BCML
- Analyst Count
- GOSS 5
- BCML 0
- Target Price
- GOSS $9.20
- BCML N/A
- AVG Volume (30 Days)
- GOSS 955.5K
- BCML 18.2K
- Earning Date
- GOSS 11-07-2024
- BCML 10-21-2024
- Dividend Yield
- GOSS N/A
- BCML 1.65%
- EPS Growth
- GOSS N/A
- BCML N/A
- EPS
- GOSS N/A
- BCML 2.12
- Revenue
- GOSS $95,842,000.00
- BCML $97,490,000.00
- Revenue This Year
- GOSS N/A
- BCML N/A
- Revenue Next Year
- GOSS N/A
- BCML $3.40
- P/E Ratio
- GOSS N/A
- BCML $11.41
- Revenue Growth
- GOSS N/A
- BCML N/A
- 52 Week Low
- GOSS $0.45
- BCML $18.54
- 52 Week High
- GOSS $1.60
- BCML $25.04
- Technical
- Relative Strength Index (RSI)
- GOSS 48.28
- BCML 62.23
- Support Level
- GOSS $0.98
- BCML $23.25
- Resistance Level
- GOSS $1.09
- BCML $24.14
- Average True Range (ATR)
- GOSS 0.06
- BCML 0.38
- MACD
- GOSS -0.01
- BCML -0.01
- Stochastic Oscillator
- GOSS 21.83
- BCML 83.97
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.